Market Research Logo

The World Market for Stents (Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROW)

The coronary stents industry is a highly competitive one in which innovation occurs rapidly and the technology landscape evolves at a fast pace. As the global population is aging and has a longer life expectancy, the prevalence of coronary heart disease and co-morbid conditions such as hypertension, diabetes and obesity is projected to rise and stimulate the demand for coronary stents. Additionally, a growing acceptance of drug-eluting stents as a more effective treatment for coronary heart disease, along with increasing awareness about coronary stents among patients, is expected to boost procedural volumes. New technologies, such as bioresorbable scaffolds, and bifurcation and biodegradable polymers stents, are projected to enter major markets in the next years and increase the utilization of stents in interventional cardiology.

Despite the challenging environment, opportunities still exist in the global market for coronary stents, as there is still a high need for non-invasive therapies with enhanced safety and efficacy, and there are various niches of the market, such as bifurcation and complex lesions, that require more extensive treatment options. Additionally, the new bioresorbable stents have the potential to eliminate the negative issues of durable polymer stents, and are therefore expected to induce a significant shift in the treatment of coronary heart disease, encouraging also more patients to undergo stent implantation surgery.

This Report, The World Market for Stents (Drug Eluting and Bare Metal Product Markets in U.S., E.U., Japan, China, India and ROW), authored by medical device analyst Adriana Rusu,  provides a complete overview of cardiovascular disease, the role of stents in treatment, the success of bare metal and drug-eluting products, as well as market sizes and forecasts to 2017. Included in this reports coverage:

  • Market Size and Forecast -Cardiovascular Disease Statistics (Mortality, Morbidity, Cost by Country)
  • Regional Breakout of Bare Metal and Drug-Eluting Stent Markets (U.S., E.U., Japan, China, India, ROW)
  • Categorization of Drug-Eluting Stents by Polymer, Drug, Platform
  • Coronary Stents Using Biodegradable Polymers, Novel Coating and Direct Drug Application
  • Assessment of Bioresorbable Stents
  • Dedicated Bifurcation, Dedicated Small Vessel Stent Products
  • Major Competitors Market Share
  • Significant Trends in Market and Near and Long-Term Impact
  • Recent Mergers and Acquisitions
  • Key Company Profiles
The major markets of US, Europe, and Japan experienced significant challenges in recent years, including price declines, decreasing volumes of percutaneous coronary interventions, and lower penetration rates for drug-eluting stents resulted from cost constraints and reductions in healthcare budgets. Additionally, the intensified competition among manufacturers also contributed to the decline in average stent selling prices in these regions. Despite that, the market potential for coronary stents in these regions remains quite attractive, given the aging population and high longevity. However, the decreasing reimbursement rates and the intensifying competition for market share are expected to continue to lead to price declines and hamper significantly the market growth.

As part of its coverage of the stents industry, the following companies are profiled:
  • Abbott Laboratories
  • Biosensors International
  • Boston Scientific
  • Biotronik SE & Co.KG
  • CID Vascular
  • Elixir Medical Corporation
  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Medical (Shanghai) Co., Ltd Minvasys
  • OrbusNeich
  • REVA Medical
  • Stentys S.A.
  • Terumo Corporation
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, science, medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical, biotechnology and contract research organizations included marketing directors, division managers, and product representatives.


  • Executive Summary
    • DISEASE OVERVIEW
      • Cardiovascular Disease
        • Table Top Ten Causes of Death in the World by Development Level, 2008
    • MARKET OVERVIEW
      • Revenue Forecast
  • Cardiovascular Disease Overview
    • DISEASE OVERVIEW
      • Top Ten Causes of Death
        • Table Top Ten Causes of Death in the World by Geographical Region, 2008
        • Table Top Ten Causes of Death in the World by Development Level, 2008
        • Table Top Ten Causes of Death in the World in High Income Countries, 2008
        • Table Top Ten Causes of Death in the World in Middle Income Countries, 2008
        • Table Top Ten Causes of Death in the World in Low Income Countries, 2008
      • World Cardiovascular Disease Statistics
        • Table Projected Deaths from Ischemic Heart Disease (IHD) and Acute Myocardial Infarction (AMI) in the Seven Major World Markets, 2012
      • Mortality Rates for IHD
        • Table Age-Standardized Mortality Rates for Ischemic Heart Disease (IHD) and Acute Myocardial Infarction (AMI) by Gender in the Seven Major World Markets, 2009
    • ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE
      • Expenditure on Cardiovascular Disease, Worldwide
        • Table Estimated Total Cost of Cardiovascular Disease in Europe, 2006
        • Table Estimated Total Cost of Cardiovascular Disease in Major Markets, 2012
      • Prevalence of Ischemic Heart Disease
  • Coronary Stents Overview
    • OVERVIEW
      • Restenosis
    • TYPES OF STENTS
      • Bare Metal Stents
        • Table Selected Marketed Bare Metal Stents, 2012
      • First Generation of Bare Metal Stents
      • Second Generation of Bare Metal Stents
      • Third Generation of Bare Metal Stents
      • Omega Platinum-Chromium Stent
      • Nuloy Molybdenum-Rhenium Stent
        • Table Selected Bare Metal Coronary Stents, 2012
      • Safety Issues of Bare Metal Stents
    • DRUG-ELUTING STENTS
      • Table Selected Marketed Drug-Eluting Stents, 2012
      • Types of Drugs Used on Drug-Eluting Stents
      • Paclitaxel
      • Sirolimus
      • Everolimus
      • Tacrolimus
      • Biolimus A9
      • Novolimus
      • Other drug classes
      • Types of Polymers
        • Table Selected Features of Different Generations of Commercially Available Drug-Eluting Stents
      • Safety Concerns of Drug-Eluting Stents
      • Late Stent Thrombosis
      • Mechanical Problems of Polymers
  • Recent Advances in Coronary Stents Technologies
    • REDUCED POLYMER COATINGS
      • Biodegradable Polymers
      • Advantages and Disadvantages of Biodegradable Polymers
      • Current Biodegradable Polymers Stents
        • Table Selected Coronary Stents using Biodegradable Polymers, 2012
      • BioMatrix
      • Nobori
      • Supralimus
      • Infinnium
      • DESyne BD stent
      • Synergy
      • MiStent
      • BioMime
      • Abrax
      • Polymer-Free and Novel Coatings Drug-eluting Stents
        • Table Selected Coronary Polymer-free and Novel Coating Stents, 2012
      • Optima Jet
      • Cre8
      • Orsiro Hybrid DES
      • EPC Capturing Technology
      • Direct Application of Drug on Stent Surface
        • Table Selected Direct Drug Application Coronary Stents, 2012
      • Amazonia Pax
      • Yukon DES
      • BioFreedom
      • Mitsu
      • Medtronic S10 platform
        • Table Selected Coronary Polymer and Drug-free Coating Stents, 2012
      • Catania stent
      • MGuard Prime
      • Titan-2
      • Bioresorbable Stents
        • Table Advantages and Disadvantages of Bioresorbable Stents
      • Drawbacks of Bioresorbable Polymeric Stents
      • Selected Bioresorbable Coronary Stents
        • Table Selected Bioresorbable Coronary Stents, 2012
      • The Absorb stent
      • Biotronik's Dreams stent
      • DESolve stent
      • ReZolve Stent
      • IDEAL stent
      • Other bioresorbable stents
    • LESION SPECIFIC STENTS
      • Dedicated Bifurcated Stents
        • Table Selected Dedicated Bifurcation Coronary Drug-Eluting Stents, 2012
      • Axxess
      • Nile Pax
      • Stentys Self-Apposing stent
      • Taxus Petal
      • Xience Side Branch Access
        • Table Selected Dedicated Small Vessels Coronary Drug-Eluting Stents, 2012
      • Sparrow
      • Taxus Liberte Atom
      • Xience nano
        • Table Drug Release Parameters of Selected Drug-Eluting Stents
  • Industry Structure
    • Table Industry Structure - Major Competitors and Selected Marketed Products, 2012
    • Sales and marketing capabilities
    • Differentiation Strategies
      • Improved stent materials
      • Reduced DAPT duration
    • Lesion-specific stents
      • Extended indications
    • Significant Trends in the Coronary Stents Market
      • Table Significant Trends in the Coronary Stents Market, 2012
    • MARKET DRIVERS
      • New devices Expanded indications
      • Acute Myocardial Infarction and Diabetes
      • Emerging Markets Are Expected To Spur The Overall Market Growth.
    • MARKET RESTRAINTS
      • Price Decline Hampers Growth In The Overall Market.
      • Cost Constraints
      • Difficult Economic Conditions
    • NOTABLE RECENT INDUSTRY EVENTS
      • Recent Mergers and Acquisitions
      • Medtronic acquired Invatec
      • Xenogenics Corporation acquired Bioabsorbable Therapeutics
      • Market Exits
  • Market Revenues and Forecast
    • Table Coronary Stents Estimated Global Market Shares, 2011
    • Table Global Market Revenues for Coronary Stents ($ Millions)
    • MARKET BY TYPE OF STENT
      • Drug Eluting Stents Market
      • Products Analysis
      • Promus Element/Plus
      • Resolute Integrity
      • Market Dynamics in the Drug-Eluting Stents Segment
    • REVENUE FORECAST
      • Table Global Market Revenues for Coronary Stents ($ Millions)
      • Bare Metal Stents Market
      • Market Dynamics
      • Revenue Forecast
        • Table Global Market Revenues for Coronary Bare Metal Stents, 2010-2017 (Bare Metal Stent, Drug Eluding Stent, Total) ($ Millions)
    • UNITED STATES
      • Market Snapshot
      • Revenue Forecast
        • Table U.S. Market Revenues for Coronary Stents (Bare Metal Stent, Drug Eluding Stent,Total) ($ Millions)
    • EUROPE
      • Market snapshot
      • Revenue Forecast
        • Table European Market Revenues for Coronary Stents (Bare Metal Stent, Drug Eluding Stent, Total) ($ Millions)
    • JAPAN
      • Market snapshot
      • Revenue forecast
        • Table Japanese Market Revenues for Coronary Stents (Bare Metal Stent, Drug Eluding Stent, Total) ($ Millions)
    • CHINA
      • Market Snapshot
      • Revenue forecast
        • Table Market Revenues for Coronary Stents in China (Bare Metal Stent, Drug Eluding Stent, Total) ($ Millions)
    • INDIA
      • Market snapshot
      • Revenue Forecast
        • Table Market Revenues for Coronary Stents in India (Bare Metal Stent, Drug Eluding Stent, Total) ($ Millions)
    • REST OF THE WORLD
      • Revenue Forecast
        • Table Market Revenues for Coronary Stents in the Rest of the World (Bare Metal Stent, Drug Eluding Stent, Total) ($ Millions)
  • Company Profiles
    • ABBOTT LABORATORIES
    • BIOSENSORS INTERNATIONAL
    • BOSTON SCIENTIFIC
    • BIOTRONIK SE&CO.KG
    • CID VASCULAR
    • ELIXIRMEDICAL CORPORATION
    • MEDTRONIC
    • MERIL LIFE SCIENCES PVT. LTD.
    • MICROPORT MEDICAL (SHANGHAI) CO., LTD
    • MINVASYS
    • ORBUSNEICH
    • REVAMEDICAL
    • STENTYS S.A.
    • TERUMO CORPORATION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report